Ocular Therapeutix Inc (OCUL)

Precedente Chiudi:

$5.84

Aprire:

$5.9

Volume 24 ore:

276.35K

Capitalizzazione di mercato:

$904.55M

Reddito:

$58.44M

Utile/perdita netta:

$-80.74M

Rapporto P/E:

-4.70

EPS:

-1.2

Flusso di cassa netto:

$-76.32M

1 W Prestazione:

-8.59%

1M Prestazione:

-28.70%

6M Prestazione:

+167.93%

1 anno Prestazione:

-12.96%

Intervallo 1D:

$5.55

$5.95

Portata 52W:

$1.995

$11.31

Ocular Therapeutix Inc Stock (OCUL) Company Profile

Nome

Ocular Therapeutix Inc

Settore

Healthcare (1221)

Industria

Biotechnology (696)

Telefono

781-357-4000

Indirizzo

15 Crosby Drive, Bedford, MA

Dipendente

119

Cinguettio

@OCUTX

Prossima data di guadagno

2024-05-15

Ultimi documenti SEC

OCUL's Discussions on Twitter

Ocular Therapeutix Inc Stock (OCUL) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-04-21	Iniziato	Robert W. Baird	Outperform
2022-08-10	Ripresa	Berenberg	Buy
2021-08-10	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-12-28	Downgrade	H.C. Wainwright	Buy → Neutral
2020-12-17	Iniziato	Berenberg	Buy
2020-11-13	Reiterato	Raymond James	Strong Buy
2020-08-10	Reiterato	H.C. Wainwright	Buy
2020-03-03	Aggiornamento	Raymond James	Outperform → Strong Buy
2019-05-21	Downgrade	Cowen	Outperform → Market Perform
2019-05-21	Reiterato	H.C. Wainwright	Buy
2019-05-21	Downgrade	Raymond James	Strong Buy → Outperform
2018-12-03	Reiterato	Cantor Fitzgerald	Overweight
2018-11-15	Iniziato	Raymond James	Strong Buy
2018-09-07	Iniziato	Piper Jaffray	Overweight
2017-10-24	Iniziato	Guggenheim	Buy
2017-07-26	Iniziato	H.C. Wainwright	Buy
2017-07-12	Reiterato	Cantor Fitzgerald	Overweight
2017-06-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2017-02-10	Iniziato	Cantor Fitzgerald	Overweight
2016-11-15	Reiterato	RBC Capital Mkts	Outperform
2016-08-11	Iniziato	JMP Securities	Mkt Outperform
2016-02-17	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight
2015-10-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2015-08-13	Iniziato	Morgan Stanley	Overweight

Mostra tutto

Ocular Therapeutix Inc Borsa (OCUL) Ultime notizie

Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences

GlobeNewswire Inc.

Ocular Therapeutix™ To Present at Two Ophthalmology Meetings, May 4-9, 2024

GlobeNewswire Inc.

Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024

GlobeNewswire Inc.

Wall Street Breakfast: The Week Ahead

Seeking Alpha

2 Small-Cap Growth Stocks With Room to Run

The Motley Fool

Ocular Therapeutix Inc Azioni (OCUL) Dati Finanziari

Ocular Therapeutix Inc (OCUL) Reddito 2024

Ocular Therapeutix Inc (OCUL) Reddito netto 2024

Ocular Therapeutix Inc (OCUL) Flusso di cassa 2024

Ocular Therapeutix Inc (OCUL) Utile per azione 2024